Bruker Corp (NASDAQ:BRKR)

53.06
Delayed Data
As of Sep 30
 +0.22 / +0.42%
Today’s Change
48.42
Today|||52-Week Range
87.22
-36.77%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$7.3B

Company Description

Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) Life Science, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The BSI Life Science segment includes enabling life science tools based on magnetic resonance technology. The BSI Nano segment offers x-ray instruments that use electromagnetic radiation with wavelengths to determine the characteristics of matter and the three-dimensional (3D) structure of molecules. The BEST segment consists of conducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research, and other applications. The company was founded by Gunther Laukien in 1960 and is headquartered in Billerica, MA.

Contact Information

Bruker Corp.
40 Manning Road
Billerica Massachusetts 01821
P:(978) 663-3660
Investor Relations:

Employees

Shareholders

Individual stakeholders68.31%
Mutual fund holders48.82%
Other institutional23.50%

Top Executives

Frank H. LaukienChairman, President & Chief Executive Officer
Gerald N. HermanChief Financial Officer & Executive Vice President
Mark Robert MunchExecutive Vice President
Jürgen SregaGroup President-Bruker CALID Segment
Falko BussePresident-Bruker BioSpin Group